Research Paper Volume 12, Issue 18 pp 18363—18383

A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer

class="figure-viewer-img"

Figure 3. Comparison analyses between ISCRC model and other known gene maker-oncotypeDX colon. (A) Univarible analyses of the ISCRC, and oncotypeDX colon to investigate the association between each prognostic index and DFS using the prognostic indexes as continuous variables in GSE39582. The blue squares on the transverse lines represent the hazard ratio (HR), and the red transverse lines represent 95% CI. (B) Receiver operating characteristic (ROC) analysis of the sensitivity and specificity of the recurrence prediction by the ISCRC model and oncotypeDX colon in GSE14333.